JP2017521433A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017521433A5 JP2017521433A5 JP2017501004A JP2017501004A JP2017521433A5 JP 2017521433 A5 JP2017521433 A5 JP 2017521433A5 JP 2017501004 A JP2017501004 A JP 2017501004A JP 2017501004 A JP2017501004 A JP 2017501004A JP 2017521433 A5 JP2017521433 A5 JP 2017521433A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid polymer
- pharmaceutically acceptable
- use according
- polymer further
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020074639A JP6922030B2 (ja) | 2014-07-10 | 2020-04-20 | Ｂ型肝炎およびｄ型肝炎ウイルス感染の治療のための方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462022846P | 2014-07-10 | 2014-07-10 | |
| US62/022,846 | 2014-07-10 | ||
| US201462091943P | 2014-12-15 | 2014-12-15 | |
| US62/091,943 | 2014-12-15 | ||
| PCT/CA2015/050626 WO2016004525A1 (en) | 2014-07-10 | 2015-07-07 | Methods for the treatment of hepatitis b and hepatitis d virus infections |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020074639A Division JP6922030B2 (ja) | 2014-07-10 | 2020-04-20 | Ｂ型肝炎およびｄ型肝炎ウイルス感染の治療のための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017521433A JP2017521433A (ja) | 2017-08-03 |
| JP2017521433A5 true JP2017521433A5 (enExample) | 2018-08-16 |
Family
ID=55063440
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017501004A Pending JP2017521433A (ja) | 2014-07-10 | 2015-07-07 | Ｂ型肝炎およびｄ型肝炎ウイルス感染の治療のための方法 |
| JP2020074639A Active JP6922030B2 (ja) | 2014-07-10 | 2020-04-20 | Ｂ型肝炎およびｄ型肝炎ウイルス感染の治療のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020074639A Active JP6922030B2 (ja) | 2014-07-10 | 2020-04-20 | Ｂ型肝炎およびｄ型肝炎ウイルス感染の治療のための方法 |
Country Status (33)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021008539A2 (pt) * | 2018-11-08 | 2021-08-03 | Aligos Therapeutics, Inc. | polímeros de oligonucleotídeos e métodos de inibição de transporte de antígeno s |
| US11166976B2 (en) | 2018-11-08 | 2021-11-09 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
| WO2021119325A1 (en) * | 2019-12-12 | 2021-06-17 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
| CN113651853A (zh) * | 2020-05-07 | 2021-11-16 | 西安新通药物研究股份有限公司 | 甲磺酸帕拉德福韦c晶型及其应用 |
| WO2021223398A1 (zh) * | 2020-05-07 | 2021-11-11 | 西安新通药物研究股份有限公司 | 治疗肝病的晶型及其应用 |
| CN114057816B (zh) * | 2020-07-30 | 2025-02-11 | 浙江柏拉阿图医药科技有限公司 | 富含腺嘌呤硫代磷酸酯化寡核苷酸及其抗肝炎病毒的应用 |
| CA3200094A1 (en) * | 2020-11-20 | 2022-05-27 | Aligos Therapeutics, Inc. | Conjugates of s-antigen transport inhibiting oligonucleotide polymers having enhanced liver targeting |
| WO2022133230A1 (en) | 2020-12-18 | 2022-06-23 | Janssen Pharmaceuticals, Inc. | Combination therapy for treating hepatitis b virus infection |
| WO2022152869A1 (en) | 2021-01-15 | 2022-07-21 | Janssen Sciences Ireland Unlimited Company | Use of oligonucleotides for individuals with hepatic impairment |
| WO2022261046A1 (en) * | 2021-06-07 | 2022-12-15 | Antios Therapeutics, Inc. | Compositions and methods of treating hepatitis d and hepatitis b/hepatitis d co-infections with phosphoramidate clevudine prodrugs |
| WO2023281434A1 (en) | 2021-07-09 | 2023-01-12 | Janssen Pharmaceuticals, Inc. | Use of oligonucleotides for individuals with renal impairment |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5482836A (en) * | 1993-01-14 | 1996-01-09 | The Regents Of The University Of California | DNA purification by triplex-affinity capture and affinity capture electrophoresis |
| EP1537208A1 (en) | 2002-09-13 | 2005-06-08 | Replicor, Inc. | Non-sequence complementary antiviral oligonucleotides |
| US9474793B2 (en) * | 2005-02-22 | 2016-10-25 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus |
| NZ606364A (en) | 2010-08-20 | 2014-12-24 | Replicor Inc | Oligonucleotide chelate complexes |
| DK2632472T3 (en) * | 2010-10-29 | 2018-03-19 | Sirna Therapeutics Inc | RNA INTERFERENCE-MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERRING NUCLEIC ACIDS (SINA) |
| WO2012075114A2 (en) * | 2010-12-01 | 2012-06-07 | Ablitech, Inc. | Nucleic acid-polymer conjugates and uses thereof |
| AR091065A1 (es) * | 2012-05-18 | 2014-12-30 | Replicor Inc | Una formulacion farmaceutica que comprende un quelato de oligonucleotidos antiviral para el tratamiento de una infeccion antiviral |
| MY168778A (en) | 2012-05-18 | 2018-12-04 | Replicor Inc | Oligonucleotide chelate complex-polypeptide compositions and methods |
| IN2015DN01087A (enExample) * | 2012-08-30 | 2015-06-26 | Replicor Inc |
-
2015
- 2015-07-07 CN CN202111146395.2A patent/CN113750112A/zh active Pending
- 2015-07-07 DK DK15818148.7T patent/DK3166615T3/da active
- 2015-07-07 KR KR1020237015821A patent/KR102734495B1/ko active Active
- 2015-07-07 SM SM20230380T patent/SMT202300380T1/it unknown
- 2015-07-07 PH PH1/2017/500010A patent/PH12017500010B1/en unknown
- 2015-07-07 RS RS20231031A patent/RS64833B1/sr unknown
- 2015-07-07 JP JP2017501004A patent/JP2017521433A/ja active Pending
- 2015-07-07 HK HK17105180.0A patent/HK1231402A1/zh unknown
- 2015-07-07 FI FIEP15818148.7T patent/FI3166615T3/fi active
- 2015-07-07 PT PT158181487T patent/PT3166615T/pt unknown
- 2015-07-07 CA CA2954182A patent/CA2954182C/en active Active
- 2015-07-07 SI SI201531976T patent/SI3166615T1/sl unknown
- 2015-07-07 HR HRP20231400TT patent/HRP20231400T1/hr unknown
- 2015-07-07 PL PL15818148.7T patent/PL3166615T3/pl unknown
- 2015-07-07 KR KR1020177003538A patent/KR20170029577A/ko not_active Ceased
- 2015-07-07 EA EA201790160A patent/EA036745B1/ru unknown
- 2015-07-07 SG SG11201700073PA patent/SG11201700073PA/en unknown
- 2015-07-07 AU AU2015286199A patent/AU2015286199B2/en not_active Ceased
- 2015-07-07 ES ES15818148T patent/ES2963814T3/es active Active
- 2015-07-07 MX MX2017000053A patent/MX381042B/es unknown
- 2015-07-07 EP EP15818148.7A patent/EP3166615B1/en active Active
- 2015-07-07 CN CN201580037179.0A patent/CN106659730A/zh active Pending
- 2015-07-07 WO PCT/CA2015/050626 patent/WO2016004525A1/en not_active Ceased
- 2015-07-07 HU HUE15818148A patent/HUE064449T2/hu unknown
- 2015-07-07 MD MDA20170014A patent/MD4760C8/ro active IP Right Grant
- 2015-07-07 MY MYPI2017700005A patent/MY178087A/en unknown
- 2015-07-07 BR BR112017000320-1A patent/BR112017000320B1/pt not_active IP Right Cessation
- 2015-07-07 LT LTEPPCT/CA2015/050626T patent/LT3166615T/lt unknown
- 2015-07-08 US US14/794,129 patent/US9603865B2/en not_active Expired - Fee Related
- 2015-07-13 TW TW104122636A patent/TWI766831B/zh active
-
2016
- 2016-12-20 IL IL249660A patent/IL249660B/en unknown
-
2017
- 2017-01-03 EC ECIEPI201697355A patent/ECSP16097355A/es unknown
- 2017-01-03 DO DO2017000002A patent/DOP2017000002A/es unknown
- 2017-01-03 CL CL2017000008A patent/CL2017000008A1/es unknown
- 2017-01-05 CU CUP2017000001A patent/CU20170001A7/es unknown
-
2020
- 2020-04-20 JP JP2020074639A patent/JP6922030B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017521433A5 (enExample) | ||
| FI3166615T3 (fi) | Kelatoituja fosforotioaattinukleiinihappopolymeerejä käytettäväksi yhdistelmänä HBV-polymeraasin inhibiittorin kanssa hepatiitti B- ja hepatiitti D -virusinfektioiden hoitamiseksi | |
| JP2015528449A5 (enExample) | ||
| MX2009012433A (es) | Azido nucleosidos de purina para el tratamiento de infecciones virales. | |
| JP2016527217A5 (enExample) | ||
| JP2016508134A5 (enExample) | ||
| CY1121639T1 (el) | Συνθεσεις που περιλαμβανουν προφαρμακα νουκλεοτιδιων και ολιγονουκλεοτιδιων | |
| JP2015512860A5 (enExample) | ||
| JP2013522302A5 (enExample) | ||
| JP2016502858A5 (enExample) | ||
| ES2982897T3 (es) | Uso del inhibidor de la telomerasa imetelstat para el tratamiento de trastornos mieloproliferativos y neoplasias mieloproliferativas | |
| JP2016531144A5 (enExample) | ||
| JP2015504650A5 (enExample) | ||
| JP2018188483A5 (enExample) | ||
| JP2009535352A5 (enExample) | ||
| JP2016503800A5 (enExample) | ||
| JP2013507439A5 (enExample) | ||
| JP2013056886A5 (enExample) | ||
| JP2015517528A5 (enExample) | ||
| JP2017513469A5 (enExample) | ||
| JP2005519916A5 (enExample) | ||
| CA2999944A1 (en) | Combination therapy of an hbv capsid assembly inhibitor and an interferon | |
| JP2015504438A5 (enExample) | ||
| CA2389745A1 (en) | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues | |
| WO2012158811A3 (en) | Purine monophosphate prodrugs for treatment of viral infections |